Anyang-si, South Korea

Sang Hoon Park



Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Sang Hoon Park in the Field of HPV and Viral Vector Technologies

Introduction

Sang Hoon Park is a notable inventor based in Anyang-si, South Korea. With a remarkable portfolio comprising three patents, Park has made significant contributions to the fields of immunology and gene delivery technologies. His innovative solutions aim to improve treatment options for diseases caused by the human papillomavirus (HPV) and enhance vaccine efficacy.

Latest Patents

Among his latest patents, one significant invention is titled "Compositions comprising HPV polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer." This invention details a fusion protein that includes a fusion polypeptide of E6 and E7 from HPV, a signal peptide for secretion, and an immune-enhancing peptide. It encompasses a pharmaceutical composition and a method for treating diseases caused by HPV using this novel composition.

Another notable patent by Park is the "Intracellular viral vector delivery method employing iron ion/viral vector composite." This method focuses on enhancing the delivery efficiency of viral vectors and gene expression across various cell types. It demonstrates excellent escape performance from virus-neutralizing antibodies, minimal cytotoxicity, and stability during iron ion processing, suggesting possible applications in recombinant viral vaccine compositions.

Career Highlights

Sang Hoon Park has a distinguished career marked by his work with recognized organizations such as the Postech Foundation and Genexine Co., Ltd. These roles have allowed him to contribute to groundbreaking research and technological advancements in his field.

Collaborations

During his professional journey, Park has collaborated with notable colleagues, including Young Chul Sung and Hyun Tak Jin. These collaborations have fostered a productive environment that encourages innovation and the sharing of ideas, further enhancing the impact of their combined research efforts.

Conclusion

In summary, Sang Hoon Park stands as an influential inventor whose work has the potential to significantly improve the arenas of HPV treatment and gene therapy. Through his patents, he showcases a commitment to advancing medical science, and his collaborations highlight the importance of teamwork in fostering innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…